{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:39:46Z","timestamp":1793936386438,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7714","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41586-018-0326-5","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T10:18:28Z","timestamp":1531304308000},"page":"405-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":858,"title":["Reprogramming human T cell function and specificity with non-viral genome targeting"],"prefix":"10.1038","volume":"559","author":[{"given":"Theodore L.","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Puig-Saus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Shifrut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Jonathan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Saco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Krystofinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Putnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Schickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Pellerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorka","family":"Alkorta-Aranburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"del Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolen M.","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channabasavaiah B.","family":"Gurumurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baz","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haugwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Esensten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Ashworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Kupfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Atma W.","family":"Greeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Meffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Roncarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Romberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan C.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel D.","family":"Leonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"326_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature22395","volume":"545","author":"M Sadelain","year":"2017","unstructured":"Sadelain, M., Rivi\u00e8re, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423\u2013431 (2017).","journal-title":"Nature"},{"key":"326_CR2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","volume":"168","author":"WA Lim","year":"2017","unstructured":"Lim, W. A. & June, C. H. The principles of engineering immune cells to treat cancer. Cell. 168, 724\u2013740 (2017).","journal-title":"Cell."},{"key":"326_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62\u201368 (2015).","journal-title":"Science"},{"key":"326_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-59745-409-4_8","volume":"506","author":"E Verhoeyen","year":"2009","unstructured":"Verhoeyen, E., Costa, C. & Cosset, F.-L. Lentiviral vector gene transfer into human T cells. Methods Mol. Biol. 506, 97\u2013114 (2009).","journal-title":"Methods Mol. Biol."},{"key":"326_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"326_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.omtm.2016.12.008","volume":"4","author":"M Hale","year":"2017","unstructured":"Hale, M. et al. Homology-directed recombination for enhanced engineering of chimeric antigen receptor T cells. Mol. Ther. Methods Clin. Dev. 4, 192\u2013203 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"326_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.4313","volume":"23","author":"TI Cornu","year":"2017","unstructured":"Cornu, T. I., Mussolino, C. & Cathomen, T. Refining strategies to translate genome editing to the clinic. Nat. Med. 23, 415\u2013423 (2017).","journal-title":"Nat. Med."},{"key":"326_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymthe.2005.07.688","volume":"13","author":"Y Zhao","year":"2006","unstructured":"Zhao, Y. et al. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol. Ther. 13, 151\u2013159 (2006).","journal-title":"Mol. Ther."},{"key":"326_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nri2690","volume":"10","author":"V Hornung","year":"2010","unstructured":"Hornung, V. & Latz, E. Intracellular DNA recognition. Nat. Rev. Immunol. 10, 123\u2013130 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"326_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012\u20131019 (2014).","journal-title":"Genome Res."},{"key":"326_CR11","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1073\/pnas.1512503112","volume":"112","author":"K Schumann","year":"2015","unstructured":"Schumann, K. et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc. Natl Acad. Sci. USA 112, 10437\u201310442 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"326_CR12","doi-asserted-by":"publisher","first-page":"E3501","DOI":"10.1073\/pnas.1606731113","volume":"113","author":"MD Leonetti","year":"2016","unstructured":"Leonetti, M. D., Sekine, S., Kamiyama, D., Weissman, J. S. & Huang, B. A scalable strategy for high-throughput GFP tagging of endogenous human proteins. Proc. Natl Acad. Sci. USA 113, E3501\u2013E3508 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"326_CR13","doi-asserted-by":"publisher","first-page":"e21856","DOI":"10.7554\/eLife.21856","volume":"6","author":"PJ Skene","year":"2017","unstructured":"Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife 6, e21856 (2017).","journal-title":"eLife"},{"key":"326_CR14","doi-asserted-by":"publisher","first-page":"e27873","DOI":"10.7554\/eLife.27873","volume":"6","author":"RO Bak","year":"2017","unstructured":"Bak, R. O. et al. Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR\/Cas9 and AAV6. eLife 6, e27873 (2017).","journal-title":"eLife"},{"key":"326_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nmeth.4265","volume":"14","author":"D Agudelo","year":"2017","unstructured":"Agudelo, D. et al. Marker-free coselection for CRISPR-driven genome editing in human cells. Nat. Methods 14, 615\u2013620 (2017).","journal-title":"Nat. Methods"},{"key":"326_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.hoc.2017.05.002","volume":"31","author":"CT Lux","year":"2017","unstructured":"Lux, C. T. & Scharenberg, A. M. Therapeutic gene editing safety and specificity. Hematol. Oncol. Clin. North Am. 31, 787\u2013795 (2017).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"326_CR17","first-page":"e62","volume":"45","author":"C Cain-Hom","year":"2017","unstructured":"Cain-Hom, C. et al. Efficient mapping of transgene integration sites and local structural changes in Cre transgenic mice using targeted locus amplification. Nucleic Acids Res. 45, e62 (2017).","journal-title":"Nucleic Acids Res."},{"key":"326_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever, D. P. et al. CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature 539, 384\u2013389 (2016).","journal-title":"Nature"},{"key":"326_CR19","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/nar\/18.9.2733","volume":"18","author":"JP Murnane","year":"1990","unstructured":"Murnane, J. P., Yezzi, M. J. & Young, B. R. Recombination events during integration of transfected DNA into normal human cells. Nucleic Acids Res. 18, 2733\u20132738 (1990).","journal-title":"Nucleic Acids Res."},{"key":"326_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K. et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540, 144\u2013149 (2016).","journal-title":"Nature"},{"key":"326_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1220-4","volume":"18","author":"RM Quadros","year":"2017","unstructured":"Quadros, R. M. et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol. 18, 92 (2017).","journal-title":"Genome Biol."},{"key":"326_CR22","doi-asserted-by":"publisher","unstructured":"Li, H. et al. Design and specificity of long ssDNA donors for CRISPR-based knock-in. Preprint at https:\/\/doi.org\/10.1101\/178905 (2017).","DOI":"10.1101\/178905"},{"key":"326_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nmeth.2649","volume":"10","author":"P Mali","year":"2013","unstructured":"Mali, P., Esvelt, K. M. & Church, G. M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957\u2013963 (2013).","journal-title":"Nat. Methods"},{"key":"326_CR24","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380\u20131389 (2013).","journal-title":"Cell"},{"key":"326_CR25","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1073\/pnas.94.7.3168","volume":"94","author":"N Sharfe","year":"1997","unstructured":"Sharfe, N., Dadi, H. K., Shahar, M. & Roifman, C. M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl Acad. Sci. USA 94, 3168\u20133171 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"326_CR26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"326_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK-H Farh","year":"2015","unstructured":"Farh, K. K.-H. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337\u2013343 (2015).","journal-title":"Nature"},{"key":"326_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature23875","volume":"549","author":"DR Simeonov","year":"2017","unstructured":"Simeonov, D. R. et al. Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 549, 111\u2013115 (2017).","journal-title":"Nature"},{"key":"326_CR29","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.4049\/jimmunol.180.9.6116","volume":"180","author":"PF Robbins","year":"2008","unstructured":"Robbins, P. F. et al. Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J. Immunol. 180, 6116\u20136131 (2008).","journal-title":"J. Immunol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0326-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-018-0326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T13:19:35Z","timestamp":1693747175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-018-0326-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"7714","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1038\/s41586-018-0326-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733616709.793548823","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/183418","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"19 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. is a co-founder of Spotlight Therapeutics. A.M. serves as an advisor to Juno Therapeutics and is a member of the scientific advisory board of PACT Pharma. The Marson laboratory has received sponsored research support (Juno Therapeutics, Epinomics, Sanofi) and a gift from Gilead. A.R. is co-founder and a member of the scientific advisory board of PACT Pharma. T.L.R., C.P.S., E.S., A.R. and A.M. are inventors on new patent applications related to this manuscript (US patent application no. 62\/520,117, T.L.R. and A.M.; US patent application no.\u00a062\/578,153,\u00a0T.L.R., C.P.S., E.S., A.R. and A.M.).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}